Related Videos - | JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Emil Dariush Lichscheidt^1,2, Zitta Barrella Harboe^3,4, Thea Kølsen Fischer^5,6

¹Infektionsmedicinsk Afdeling, Aarhus Universitetshospital.

Ugeskrift for Laeger

|March 27, 2024

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Early impact of RSV prevention on infant hospitalisations in Denmark.

The Lancet regional health. Europe·2026

Same author

Risk of Mortality and Cardiovascular Events in Patients with Chronic Obstructive Pulmonary Disease Treated with Azithromycin, Roxithromycin, Clarithromycin and Amoxicillin in Primary and Secondary Care.

Biomedicines·2026

Same author

Hybrid Hospital at Home and Physical Activity for Adults Admitted to the Hospital With Acute Illness: A Randomized Clinical Trial.

JAMA network open·2026

Same author

Effect of RSV Vaccine in Older Adults with Atrial Fibrillation: A Prespecified Analysis of the DAN-RSV Trial.

European journal of preventive cardiology·2026

Same author

Novel Partial Loss-of-function STAT3-variant as Cause of Hyper-IgE-Syndrome in a Danish Family with Variable Expressivity.

Journal of clinical immunology·2026

Same author

Epidemiological and genomic features of chikungunya virus disease in travellers returning from Cuba, September 2025 to January 2026: a GeoSentinel analysis.

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2026

New vaccines offer protection against respiratory syncytial virus (RSV), a common cause of severe illness in infants and older adults. Vaccination decisions for the elderly should be individualized based on risk and shared decision-making.

Area of Science:

Virology
Immunology
Public Health

Context:

Respiratory syncytial virus (RSV) is a significant pathogen causing substantial illness and death, particularly in vulnerable populations like infants, the elderly, and immunocompromised individuals.
The recent approval of two vaccines, Abrysvo and Arexvy, marks a significant advancement in preventing severe RSV disease.

Purpose:

To inform healthcare providers and the public about the availability and approved uses of new RSV vaccines.
To highlight the importance of considering vaccination for high-risk elderly individuals.

Summary:

Abrysvo and Arexvy are approved for preventing severe RSV infection in adults aged 60 and older.
Abrysvo is also approved for use during pregnancy to protect infants from RSV-associated lower respiratory tract infections.

Related Experiment Videos

While national recommendations are pending, shared clinical decision-making is advised for vaccinating elderly individuals at high risk.

Impact:

These vaccines represent a crucial new tool in mitigating the burden of RSV disease.
Vaccination can reduce hospitalizations and mortality associated with RSV, especially in elderly and infant populations.
The introduction of these vaccines necessitates updated clinical guidelines and public health strategies for RSV prevention.